UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: July 2011

ROSETTA GENOMICS LTD.
(Exact name of registrant as specified in its charter)
 
Israel
(State or Other Jurisdiction of Incorporation 
 
10 Plaut Street, Science Park
Rehovot 76706 POB 4059
Israel
(Address of Principal Executive Offices) 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-For Form 40-F:
x   Form 20-F          o Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):         o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):         o

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:           o Yes          No x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):      n/a     

 
 
 
 
Rosetta Genomics Ltd.

On July 21, 2011, Rosetta Genomics Ltd. (the “Company”) was notified by The NASDAQ Stock Market that, as a result of the Company’s ordinary shares having a closing bid price of $1.00 per share or more for a minimum of 10 consecutive trading days, it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The Company issued a press release on July 21, 2011 regarding this matter and a copy of the press release is attached as Exhibit 99.1 to this Report and is incorporated herein by reference.

The information contained in this Report (including the Exhibit) is hereby incorporated by reference into the Company’s Registration Statements on Form F-3, File Nos. 333-159955, 333-163063, 333-171203 and 333-172655.

Exhibits

Exhibit
   
Number
 
Description of Exhibit
99.1 
 
Press release dated July 21, 2011.

 
 
 
 
Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ROSETTA GENOMICS LTD.
 
       
Date: July 21, 2011 
By:
/s/ Tami Fishman Jutkowitz  
 
   
Tami Fishman Jutkowitz
 
   
General Counsel
 
       
 
 
 
 
Rosetta Genomics Ltd. (MM) (NASDAQ:ROSGD)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Rosetta Genomics Ltd. (MM) Charts.
Rosetta Genomics Ltd. (MM) (NASDAQ:ROSGD)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Rosetta Genomics Ltd. (MM) Charts.